RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Barrett's esophagus
Accession: DOID:9206
browse the term
Definition: An esophageal disease characterized by a change of normal esophageal squamous epithelium to a columnar and intestinal-type epithelium. (DO)
Synonyms: exact_synonym: Barrett epithelium; Barrett esophagus; Barrett metaplasia; Barrett syndrome; Barrett's Syndrome; Barrett's esophagus with esophagitis; Barrett's oesophagus; Barrett's ulcer of esophagus; Barretts Esophagus; Barretts syndrome; ulcerative esophagitis
narrow_synonym: BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA; BARRETT METAPLASIA ADENOCARCINOMA OF ESOPHAGUS
primary_id: MESH:D001471
alt_id: MIM:614266
xref: EFO:0000280 ; GARD:20 ; ICD10CM:K22.7 ; ICD9CM:530.85 ; NCI:C2891
GViewer not supported for the selected species.
G
ASCC1
activating signal cointegrator 1 complex subunit 1
ISO
ClinVar Annotator: match by term: Barrett esophagus | ClinVar Annotator: match by term: Barrett esophagus/esophageal adenocarcinoma
OMIM ClinVar
PMID:21791690 PMID:25741868 PMID:28492532
NCBI chr 9:59,095,335...59,205,646
Ensembl chr 9:59,097,501...59,204,874
G
B3GAT2
beta-1,3-glucuronyltransferase 2
ISO
DNA:hypermethylation:esophageal squamous epithelium
RGD
PMID:26545406
RGD:11552890
NCBI chr17:4,080,648...4,150,371
Ensembl chr17:4,081,403...4,149,335
G
BECN1
beclin 1
disease_progression
ISO
RGD
PMID:22301112
RGD:11561943
NCBI chr16:63,469,187...63,482,627
Ensembl chr16:63,469,192...63,485,322
G
BMP4
bone morphogenetic protein 4
ISO
protein:increased expression:esophagus:
RGD
PMID:17570215
RGD:8699511
NCBI chr24:31,097,673...31,104,774
Ensembl chr24:31,097,538...31,101,225
G
CDH13
cadherin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18729198
NCBI chr 5:68,048,655...69,213,102
Ensembl chr 5:68,451,894...69,211,534
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:nucleus of esophagus mucosa:
RGD
PMID:11753681
RGD:8662398
NCBI chr17:35,445,668...35,454,334
Ensembl chr17:35,445,223...35,454,342
G
CDX2
caudal type homeobox 2
disease_progression
ISO
RGD
PMID:23011828
RGD:7349348
NCBI chr 3:7,080,142...7,088,010
Ensembl chr 3:7,078,503...7,087,285
G
CTHRC1
collagen triple helix repeat containing 1
ISO
ClinVar Annotator: match by term: Barrett esophagus/esophageal adenocarcinoma
OMIM ClinVar
PMID:21791690
NCBI chr 8:98,227,661...98,239,984
Ensembl chr 8:98,227,705...98,240,753
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15387324
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
G
FOXP1
forkhead box P1
ISO
DNA:snp:enhancer:g.70879779A>C (rs2687201) (human)
RGD
PMID:25447851
RGD:11560527
NCBI chr22:31,907,941...32,538,294
Ensembl chr22:31,912,460...32,154,502
G
GAST
gastrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15387324
NCBI chr16:64,526,548...64,532,145
Ensembl chr16:64,526,636...64,527,080
G
GATA6
GATA binding protein 6
disease_progression
ISO
protein:increased expression: esophagus squamous epithelium (human)
RGD
PMID:25445407
RGD:13208870
NCBI chr18:58,312,328...58,345,472
Ensembl chr18:58,311,482...58,343,746
G
GPX3
glutathione peroxidase 3
ISO
DNA:hypermethylation:promoter
RGD
PMID:18664505
RGD:151665749
NCBI chr23:53,576,950...53,585,321
G
GPX7
glutathione peroxidase 7
ISO
DNA:hypermethylation:promoter
RGD
PMID:18664505
RGD:151665749
NCBI chr20:80,335,248...80,342,687
Ensembl chr20:80,335,033...80,342,124
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15387324
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
G
IGFBP3
insulin like growth factor binding protein 3
ISO
associated with Aneuploidy; protein:increased expression:serum:
RGD
PMID:18006928
RGD:12743582
NCBI chr21:12,905,309...12,914,199
Ensembl chr21:12,905,280...12,914,205
G
LOC103216270
cytochrome P450 26A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18059332
NCBI chr 9:86,310,142...86,328,622
Ensembl chr 9:86,325,401...86,328,775
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21127259
G
MKI67
marker of proliferation Ki-67
severity
ISO
RGD
PMID:22147251
RGD:6483521
NCBI chr 9:120,697,183...120,727,039
Ensembl chr 9:120,698,834...120,726,866
G
MMP1
matrix metallopeptidase 1
ISO
DNA:insertion:promoter:g.-1607insG (rs1799750) (human)
RGD
PMID:19321798
RGD:7207058
NCBI chr 1:94,167,507...94,177,357
Ensembl chr 1:94,167,219...94,176,767
G
MMP12
matrix metallopeptidase 12
ISO
DNA:snp:promoter:g.-82A>G rs2276109 (human)
RGD
PMID:19321798
RGD:7207058
NCBI chr 1:94,243,061...94,261,035
Ensembl chr 1:94,243,875...94,259,591
G
MSR1
macrophage scavenger receptor 1
ISO
ClinVar Annotator: match by term: Barrett esophagus | ClinVar Annotator: match by term: Barrett esophagus/esophageal adenocarcinoma | ClinVar Annotator: match by term: Barrett's esophagus
OMIM ClinVar
PMID:12244320 PMID:12958598 PMID:21791690 PMID:24082139 PMID:25333069 PMID:25741868 PMID:28492532 More...
NCBI chr 8:14,221,389...14,305,059
Ensembl chr 8:14,220,529...14,304,946
G
MUC2
mucin 2, oligomeric mucus/gel-forming
disease_progression
ISO
RGD
PMID:23011828
RGD:7349348
NCBI chr 1:893,554...926,854
G
NR1I2
nuclear receptor subfamily 1 group I member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21977915
NCBI chr22:61,005,404...61,043,016
Ensembl chr22:61,006,667...61,040,832
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15387324
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
PTGES
prostaglandin E synthase
ISO
mRNA:increased expression:esophagus
RGD
PMID:14684572
RGD:2300107
NCBI chr12:8,393,462...8,408,441
Ensembl chr12:8,393,550...8,408,435
G
PTGS2
prostaglandin-endoperoxide synthase 2
disease_progression
ISO
mRNA: increased expression: Esophagus CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11059772 PMID:12105834 PMID:15387324 PMID:17244951 PMID:17675820 PMID:23011828 More...
RGD:13207438 RGD:1642603 RGD:7349348
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15387324
NCBI chr 1:8,576,059...8,585,561
Ensembl chr 1:8,576,542...8,586,516
G
RPRM
reprimo, TP53 dependent G2 arrest mediator homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17121882
NCBI chr10:38,863,940...38,865,912
Ensembl chr10:38,864,844...38,865,170
G
SLC9A1
solute carrier family 9 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21127259
NCBI chr20:105,613,289...105,670,868
Ensembl chr20:105,613,338...105,674,208
G
SMO
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:23108119
RGD:150340553
NCBI chr21:97,788,955...97,814,549
Ensembl chr21:97,788,624...97,814,709
G
SST
somatostatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17999418
NCBI chr15:81,946,287...81,947,775
Ensembl chr15:81,946,206...81,947,790
G
VDR
vitamin D receptor
susceptibility
ISO
DNA:SNPs,haplotype:exon:rs1989969,rs2238135 (human)
RGD
PMID:25910066
RGD:11055189
NCBI chr11:44,062,198...44,126,295
Ensembl chr11:44,065,457...44,166,684
G
ZNF793
zinc finger protein 793
ISO
DNA:hypermethylation:esophageal squamous epithelium
RGD
PMID:26545406
RGD:11552890
NCBI chr 6:32,165,455...32,224,056
Ensembl chr 6:32,217,307...32,222,748
G
RAD21
RAD21 cohesin complex component
ISO
ClinVar Annotator: match by term: Mungan syndrome
OMIM ClinVar
PMID:14638363 PMID:18414213 PMID:25575569 PMID:25741868 PMID:28492532
NCBI chr 8:111,486,356...111,515,641
Ensembl chr 8:111,486,048...111,507,729
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all